1. Home
  2. Detail

@prasetyambrata: #onthisday

Prasetya M Brata
Prasetya M Brata
Open In TikTok:
Region: ID
Saturday 12 September 2026 23:08:14 GMT
280
30
3
0

Music

Download

No Watermark .mp4 (2.42MB) No Watermark(HD) .mp4 (2.42MB) Watermark .mp4 (4.8MB) Music .mp3

Comments

kisabda
Abah Guru Jadug :
satu orang peserta juga cukup, jika rutin dan investasinya Kakap... 😁
2026-09-13 05:17:26
2
ridwan.hamid_94
Ridwan Hamid :
💪💪💪
2026-09-13 01:41:11
0
To see more videos from user @prasetyambrata, please go to the Tikwm homepage.

Other Videos

🔥 LIMITED TIME MOMCOZY DEALS 🔥 Don’t miss these exclusive savings 👇 1️⃣ M9 Breast Pump June 23–26 ONLY: 💥 20% OFF + EXTRA 10% OFF with code PUMP10JSEK 2️⃣ Bras & Belly Bands 💥 FLAT 30% OFF with code JYOTIMOM30 at Momcozy 💗 Designed for comfort. Loved by moms. Trusted for everyday support. ⏳ These deals won’t last—shop now before they’re gone! @momcozyUS @Momcozy-us #momcozyprimeday #momcozybreastpumps #momcozym9 #momcozynursingbras #primeday
🔥 LIMITED TIME MOMCOZY DEALS 🔥 Don’t miss these exclusive savings 👇 1️⃣ M9 Breast Pump June 23–26 ONLY: 💥 20% OFF + EXTRA 10% OFF with code PUMP10JSEK 2️⃣ Bras & Belly Bands 💥 FLAT 30% OFF with code JYOTIMOM30 at Momcozy 💗 Designed for comfort. Loved by moms. Trusted for everyday support. ⏳ These deals won’t last—shop now before they’re gone! @momcozyUS @Momcozy-us #momcozyprimeday #momcozybreastpumps #momcozym9 #momcozynursingbras #primeday
Bí kíp 'hẹn hò' với Văn Công Tử MONO chỉ bằng một phần gà rán @Lotteria Vietnam Tag ngay đứa bạn để cùng đi test nhân phẩm nào! 🤭 Săn Secret Card Mở Khoá Cuộc Hẹn cùng MONO #LotteriaVietnam #TasteTheFun #LotteriawithMono #ThiViCay #MONO
Bí kíp 'hẹn hò' với Văn Công Tử MONO chỉ bằng một phần gà rán @Lotteria Vietnam Tag ngay đứa bạn để cùng đi test nhân phẩm nào! 🤭 Săn Secret Card Mở Khoá Cuộc Hẹn cùng MONO #LotteriaVietnam #TasteTheFun #LotteriawithMono #ThiViCay #MONO
@CÙNG LÀM MẸ Con từ 4 tuổi các mẹ đã có thể cho con làm quen môn toán , dạy con theo phương pháp Montessori sẽ giúp con hiểu bài và tiếp thu nhanh hơn đấy các mom ơi !! #sachchobe #hanhtrangvaolopmot #reviewmevabe #dayconthongminh #sachhaychobe
@CÙNG LÀM MẸ Con từ 4 tuổi các mẹ đã có thể cho con làm quen môn toán , dạy con theo phương pháp Montessori sẽ giúp con hiểu bài và tiếp thu nhanh hơn đấy các mom ơi !! #sachchobe #hanhtrangvaolopmot #reviewmevabe #dayconthongminh #sachhaychobe
#وقفت مثل سيف صامل بحربك💔#اكسبلورexplore #لايك_متابعه_اكسبلور #شيلات #هشتاق
#وقفت مثل سيف صامل بحربك💔#اكسبلورexplore #لايك_متابعه_اكسبلور #شيلات #هشتاق
Mình về chung một nhà nhé ❤️ - Cưới Nhau Đi (Yes I Do) - Bùi Anh Tuấn, Hiền Hồ #cuoinhaudi #yesido #hienho #buianhtuan #nhachaymoingay #nhachay #chatchill #music #amnhac #tinhyeu #tinhcam #tamtrang #cover #xuhuong2023
Mình về chung một nhà nhé ❤️ - Cưới Nhau Đi (Yes I Do) - Bùi Anh Tuấn, Hiền Hồ #cuoinhaudi #yesido #hienho #buianhtuan #nhachaymoingay #nhachay #chatchill #music #amnhac #tinhyeu #tinhcam #tamtrang #cover #xuhuong2023
Mounjaro, also called tirzepatide, is now FDA-approved to reduce major cardiovascular events in adults with type 2 diabetes who are at high cardiovascular risk. That last part matters. This is not a broad heart-protection indication for everyone using tirzepatide for weight loss. It applies specifically to high-risk adults with type 2 diabetes. The approval was based on SURPASS-CVOT, which followed 13,299 patients and compared Mounjaro with Trulicity, a medication already proven to provide cardiovascular benefit. Mounjaro produced an 8% lower rate of major cardiovascular events, but it established noninferiority, not statistical superiority. This is still an important expansion. Mounjaro is no longer FDA-approved only for blood-sugar control. It now carries a formal cardiovascular risk-reduction indication for the right patients. And one clarification: Mounjaro, not Zepbound, received this specific indication. Both contain tirzepatide, but FDA approvals follow the brand and patient population.
Mounjaro, also called tirzepatide, is now FDA-approved to reduce major cardiovascular events in adults with type 2 diabetes who are at high cardiovascular risk. That last part matters. This is not a broad heart-protection indication for everyone using tirzepatide for weight loss. It applies specifically to high-risk adults with type 2 diabetes. The approval was based on SURPASS-CVOT, which followed 13,299 patients and compared Mounjaro with Trulicity, a medication already proven to provide cardiovascular benefit. Mounjaro produced an 8% lower rate of major cardiovascular events, but it established noninferiority, not statistical superiority. This is still an important expansion. Mounjaro is no longer FDA-approved only for blood-sugar control. It now carries a formal cardiovascular risk-reduction indication for the right patients. And one clarification: Mounjaro, not Zepbound, received this specific indication. Both contain tirzepatide, but FDA approvals follow the brand and patient population.

About

Legal